290 related articles for article (PubMed ID: 33162074)
1. Molecular basis of the anti-diabetic properties of camel milk through profiling of its bioactive peptides on dipeptidyl peptidase IV (DPP-IV) and insulin receptor activity.
Ashraf A; Mudgil P; Palakkott A; Iratni R; Gan CY; Maqsood S; Ayoub MA
J Dairy Sci; 2021 Jan; 104(1):61-77. PubMed ID: 33162074
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in camel milk protein hydrolysates.
Nongonierma AB; Paolella S; Mudgil P; Maqsood S; FitzGerald RJ
Food Chem; 2018 Apr; 244():340-348. PubMed ID: 29120791
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV (DPP-IV) inhibitory properties of a camel whey protein enriched hydrolysate preparation.
Nongonierma AB; Cadamuro C; Le Gouic A; Mudgil P; Maqsood S; FitzGerald RJ
Food Chem; 2019 May; 279():70-79. PubMed ID: 30611514
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory properties of camel whey protein hydrolysates toward liver cancer cells, dipeptidyl peptidase-IV, and inflammation.
Kamal H; Jafar S; Mudgil P; Murali C; Amin A; Maqsood S
J Dairy Sci; 2018 Oct; 101(10):8711-8720. PubMed ID: 30122417
[TBL] [Abstract][Full Text] [Related]
5. Characterization and identification of novel antidiabetic and anti-obesity peptides from camel milk protein hydrolysates.
Mudgil P; Kamal H; Yuen GC; Maqsood S
Food Chem; 2018 Sep; 259():46-54. PubMed ID: 29680061
[TBL] [Abstract][Full Text] [Related]
6. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
[TBL] [Abstract][Full Text] [Related]
7. Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties.
Nongonierma AB; Maux SL; Esteveny C; FitzGerald RJ
J Sci Food Agric; 2017 Mar; 97(4):1093-1101. PubMed ID: 27271791
[TBL] [Abstract][Full Text] [Related]
8. In vitro antidiabetic and antihypercholesterolemic activities of camel milk protein hydrolysates derived upon simulated gastrointestinal digestion of milk from different camel breeds.
Mudgil P; Redha AA; Nirmal NP; Maqsood S
J Dairy Sci; 2023 May; 106(5):3098-3108. PubMed ID: 36935238
[TBL] [Abstract][Full Text] [Related]
9. Simulated gastrointestinal digestion of camel and bovine casein hydrolysates: Identification and characterization of novel anti-diabetic bioactive peptides.
Mudgil P; Kamal H; Priya Kilari B; Mohd Salim MAS; Gan CY; Maqsood S
Food Chem; 2021 Aug; 353():129374. PubMed ID: 33740505
[TBL] [Abstract][Full Text] [Related]
10. Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity.
Nongonierma AB; FitzGerald RJ
Peptides; 2016 May; 79():1-7. PubMed ID: 26988873
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis.
Nongonierma AB; FitzGerald RJ
Food Chem; 2014 Feb; 145():845-52. PubMed ID: 24128555
[TBL] [Abstract][Full Text] [Related]
12. Preparation, identification, and inhibitory mechanism of dipeptidyl peptidase IV inhibitory peptides from goat milk whey protein.
Du X; Jiang C; Wang S; Jing H; Mo L; Ma C; Wang H
J Food Sci; 2023 Aug; 88(8):3577-3593. PubMed ID: 37458288
[TBL] [Abstract][Full Text] [Related]
13. Investigation into the bioavailability of milk protein-derived peptides with dipeptidyl-peptidase IV inhibitory activity using Caco-2 cell monolayers.
Lacroix IME; Chen XM; Kitts DD; Li-Chan ECY
Food Funct; 2017 Feb; 8(2):701-709. PubMed ID: 28098291
[TBL] [Abstract][Full Text] [Related]
14. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes.
Power O; Nongonierma AB; Jakeman P; FitzGerald RJ
Proc Nutr Soc; 2014 Feb; 73(1):34-46. PubMed ID: 24131508
[TBL] [Abstract][Full Text] [Related]
15. Identification of DPP-IV inhibitory peptides derived from buffalo colostrum: Mining through bioinformatics, in silico and in vitro approaches.
Ashok A; H S A
J Mol Recognit; 2024 Jul; 37(4):e3090. PubMed ID: 38803118
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of dipeptidyl peptidase-IV inhibitory peptides from trypsin-hydrolyzed α-lactalbumin-rich whey proteins.
Jia CL; Hussain N; Joy Ujiroghene O; Pang XY; Zhang SW; Lu J; Liu L; Lv JP
Food Chem; 2020 Jul; 318():126333. PubMed ID: 32151919
[TBL] [Abstract][Full Text] [Related]
17. Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins.
Nongonierma AB; FitzGerald RJ
J Food Biochem; 2019 Jan; 43(1):e12451. PubMed ID: 31353485
[TBL] [Abstract][Full Text] [Related]
18. New insights into the cholesterol esterase- and lipase-inhibiting potential of bioactive peptides from camel whey hydrolysates: Identification, characterization, and molecular interaction.
Baba WN; Mudgil P; Baby B; Vijayan R; Gan CY; Maqsood S
J Dairy Sci; 2021 Jul; 104(7):7393-7405. PubMed ID: 33934858
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
20. Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors.
Tulipano G; Sibilia V; Caroli AM; Cocchi D
Peptides; 2011 Apr; 32(4):835-8. PubMed ID: 21256171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
